A unique offering for the maximum diversity of batch, expiry, and origin conditions for EU clinical trial material
One of our valued clients is a large multinational pharmaceutical company, harnessing new technologies to develop medicines that address unmet medical needs. Their expansive clinical pipeline covers indications where there are already standards of care and multiple lines of potential treatments if the first line is insufficient.
A unique solution to drastically reduce client exposure to unplanned clinical trial costs associated with unpredictable comparator overages.
As clinical trials are increasingly designed to compare new assets with existing gold standard therapies such as Humira, Keytruda and other high cost reference medicines, the cost of the comparator drug budget is becoming a significant proportion of the total trial budget.
Simplyfying medicine access and growth in the Nordics.
Read our case study on how Abacus Medicine Pharma Services has helped several clients identify a larger potential for sales growth and operational effectiveness.
Multi market EU launch, promotion and distribution.
Read our case study on how Abacus Medicine Pharma Services has developed a multi market access strategy for a client to successfully launch, promote, and distribute a rare disease product in 10 EU countries.